BCAX

Healthcare Biotechnology

Bicara Therapeutics Inc.

$17.63

-0.57 -3.13% today

Price History

Not enough data

Key Stats

Market Cap

1.16B

Avg Volume

621,414

EPS

-$3.07

52W High

$30.99

52W Low

$13.70

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-5.08

P/B Ratio

2.48

EV/EBITDA

-3.32

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(41.0%)

Return on Assets

(26.1%)

Liquidity & Leverage

Current Ratio

11.59

Quick Ratio

11.44

Debt / Equity

0.00

Total Cash

497.26M

Total Debt

1.16M

About

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.